Half-year report · HY
4937.TEDINET S100Y3R1
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥835m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥138m | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | −¥52m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥135m | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥152m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥135m | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥136m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥44m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥136m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥3.4bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥3.0bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.2bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.2bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥163m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥136m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥10m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥189m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥88m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥92m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥150m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥123m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥38.63 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.32 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.36 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥38.41 | 2025-10-01 → 2026-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥12.24 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 65.6% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-10-01 → 2026-03-31 | ¥126m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-10-01 → 2026-03-31 | ¥126m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-10-01 → 2026-03-31 | ¥95m |
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥539,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥539,000 |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥208m |
| Direct To Consumer Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥376m |
| Direct To Consumer Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥376m |
| Direct To Consumer Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥163m |
| Medical Supportreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥632m |
| Medical Supportreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥632m |
| Medical Supportreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| Medical Supportreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥88m |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥1.0bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥1.0bn |
| —segment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | ¥251m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-10-01 → 2026-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-10-01 → 2026-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-10-01 → 2026-03-31 | ¥346m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥187m |
| Direct To Consumer Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥503m |
| Direct To Consumer Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥503m |
| Direct To Consumer Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥144m |
| Medical Supportreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥332m |
| Medical Supportreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥332m |
| Medical Supportreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥9m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 455
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人クレア | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)橘内 進 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)塚田 英樹 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 834854000 | JPY |
| Net sales (5-year summary) | InterimDuration | 1133473000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 1960902000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | -54568000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 134535000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 152398000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | -59163000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 136485000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 44090000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | -59163000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | 136485000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 44090000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 2064037000 | JPY |
| Net assets (5-year summary) | InterimInstant | 2243499000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 2091650000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 3027801000 | JPY |
| Total assets (5-year summary) | InterimInstant | 3397952000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 3199164000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | -16.36 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 38.63 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 12.32 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | － | |
| Diluted earnings per share (5-year summary) | InterimDuration | 38.41 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 12.24 | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.679 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.656 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.651 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | 9953000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | 162953000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 136344000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -88054000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -3634000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -188950000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | -122701000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | -92354000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -150424000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 1304528000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 1369266000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1302301000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3643068 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3663068 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 3643068 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 3663068 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 1918454 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.5414 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |